324 related articles for article (PubMed ID: 17140695)
21. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer.
Gu J; Berman D; Lu C; Wistuba II; Roth JA; Frazier M; Spitz MR; Wu X
Clin Cancer Res; 2006 Dec; 12(24):7329-38. PubMed ID: 17189404
[TBL] [Abstract][Full Text] [Related]
22. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
[TBL] [Abstract][Full Text] [Related]
24. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
[TBL] [Abstract][Full Text] [Related]
25. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H
Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875
[TBL] [Abstract][Full Text] [Related]
26. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT
Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560
[TBL] [Abstract][Full Text] [Related]
27. Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.
Wang J; Bhutani M; Pathak AK; Lang W; Ren H; Jelinek J; He R; Shen L; Issa JP; Mao L
Cancer Res; 2007 Nov; 67(22):10647-52. PubMed ID: 18006804
[TBL] [Abstract][Full Text] [Related]
28. High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile.
Guzman LM; Koriyama C; Akiba S; Eizuru Y; Castillo D; Corvalan A; Aguayo FR
Biol Res; 2007; 40(3):365-72. PubMed ID: 18449464
[TBL] [Abstract][Full Text] [Related]
29. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer.
Wang L; Wang J; Sun S; Rodriguez M; Yue P; Jang SJ; Mao L
Int J Oncol; 2006 Jul; 29(1):201-7. PubMed ID: 16773201
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
32. MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
Tada Y; Wada M; Kuroiwa K; Kinugawa N; Harada T; Nagayama J; Nakagawa M; Naito S; Kuwano M
Clin Cancer Res; 2000 Dec; 6(12):4618-27. PubMed ID: 11156211
[TBL] [Abstract][Full Text] [Related]
33. De novo CpG island methylation in human cancer cells.
Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
[TBL] [Abstract][Full Text] [Related]
34. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
36. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
Hattori N; Abe T; Hattori N; Suzuki M; Matsuyama T; Yoshida S; Li E; Shiota K
Genome Res; 2004 Sep; 14(9):1733-40. PubMed ID: 15310660
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
[TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity.
Yakushiji T; Uzawa K; Shibahara T; Noma H; Tanzawa H
Int J Oncol; 2003 Jun; 22(6):1201-7. PubMed ID: 12738984
[TBL] [Abstract][Full Text] [Related]
40. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
Huang QM; Tomida S; Masuda Y; Arima C; Cao K; Kasahara TA; Osada H; Yatabe Y; Akashi T; Kamiya K; Takahashi T; Suzuki M
Cancer Res; 2010 Nov; 70(21):8407-16. PubMed ID: 20861182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
